267 related articles for article (PubMed ID: 37388700)
1. Uncovering the Kinetic Characteristics and Degradation Preference of PROTAC Systems with Advanced Theoretical Analyses.
Tang R; Wang Z; Xiang S; Wang L; Yu Y; Wang Q; Deng Q; Hou T; Sun H
JACS Au; 2023 Jun; 3(6):1775-1789. PubMed ID: 37388700
[TBL] [Abstract][Full Text] [Related]
2. SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation Rate.
Roy MJ; Winkler S; Hughes SJ; Whitworth C; Galant M; Farnaby W; Rumpel K; Ciulli A
ACS Chem Biol; 2019 Mar; 14(3):361-368. PubMed ID: 30721025
[TBL] [Abstract][Full Text] [Related]
3. Kinetic Detection of E3:PROTAC:Target Ternary Complexes Using NanoBRET Technology in Live Cells.
Mahan SD; Riching KM; Urh M; Daniels DL
Methods Mol Biol; 2021; 2365():151-171. PubMed ID: 34432243
[TBL] [Abstract][Full Text] [Related]
4. Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders.
Setia N; Almuqdadi HTA; Abid M
Eur J Med Chem; 2024 Feb; 265():116041. PubMed ID: 38199162
[TBL] [Abstract][Full Text] [Related]
5. Degradation of proteins by PROTACs and other strategies.
Wang Y; Jiang X; Feng F; Liu W; Sun H
Acta Pharm Sin B; 2020 Feb; 10(2):207-238. PubMed ID: 32082969
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of PROTAC cooperative recognition for selective protein degradation.
Gadd MS; Testa A; Lucas X; Chan KH; Chen W; Lamont DJ; Zengerle M; Ciulli A
Nat Chem Biol; 2017 May; 13(5):514-521. PubMed ID: 28288108
[TBL] [Abstract][Full Text] [Related]
7. Trivalent PROTACs enhance protein degradation via combined avidity and cooperativity.
Imaide S; Riching KM; Makukhin N; Vetma V; Whitworth C; Hughes SJ; Trainor N; Mahan SD; Murphy N; Cowan AD; Chan KH; Craigon C; Testa A; Maniaci C; Urh M; Daniels DL; Ciulli A
Nat Chem Biol; 2021 Nov; 17(11):1157-1167. PubMed ID: 34675414
[TBL] [Abstract][Full Text] [Related]
8. Impact of PROTAC Linker Plasticity on the Solution Conformations and Dissociation of the Ternary Complex.
Weerakoon D; Carbajo RJ; De Maria L; Tyrchan C; Zhao H
J Chem Inf Model; 2022 Jan; 62(2):340-349. PubMed ID: 35018781
[TBL] [Abstract][Full Text] [Related]
9. General Stepwise Approach to Optimize a TR-FRET Assay for Characterizing the BRD/PROTAC/CRBN Ternary Complex.
Lin W; Chen T
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):941-952. PubMed ID: 33860212
[TBL] [Abstract][Full Text] [Related]
10. Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders.
Diehl CJ; Ciulli A
Chem Soc Rev; 2022 Oct; 51(19):8216-8257. PubMed ID: 35983982
[TBL] [Abstract][Full Text] [Related]
11. PROTAC-induced Protein Functional Dynamics in Targeted Protein Degradation.
Wu KY; Hung TI; Chang CA
bioRxiv; 2024 May; ():. PubMed ID: 38746111
[TBL] [Abstract][Full Text] [Related]
12. PRosettaC: Rosetta Based Modeling of PROTAC Mediated Ternary Complexes.
Zaidman D; Prilusky J; London N
J Chem Inf Model; 2020 Oct; 60(10):4894-4903. PubMed ID: 32976709
[TBL] [Abstract][Full Text] [Related]
13. Structure-Based Design of a Macrocyclic PROTAC.
Testa A; Hughes SJ; Lucas X; Wright JE; Ciulli A
Angew Chem Int Ed Engl; 2020 Jan; 59(4):1727-1734. PubMed ID: 31746102
[TBL] [Abstract][Full Text] [Related]
14. Crystallization of VHL-based PROTAC-induced ternary complexes.
Wijaya AJ; Farnaby W; Ciulli A
Methods Enzymol; 2023; 681():241-263. PubMed ID: 36764760
[TBL] [Abstract][Full Text] [Related]
15. Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4.
Zengerle M; Chan KH; Ciulli A
ACS Chem Biol; 2015 Aug; 10(8):1770-7. PubMed ID: 26035625
[TBL] [Abstract][Full Text] [Related]
16. An In Vitro Pull-down Assay of the E3 Ligase:PROTAC:Substrate Ternary Complex to Identify Effective PROTACs.
Bondeson DP; Smith BE; Buhimschi AD
Methods Mol Biol; 2021; 2365():135-150. PubMed ID: 34432242
[TBL] [Abstract][Full Text] [Related]
17. Native mass spectrometry and gas-phase fragmentation provide rapid and in-depth topological characterization of a PROTAC ternary complex.
Song JH; Wagner ND; Yan J; Li J; Huang RY; Balog AJ; Newitt JA; Chen G; Gross ML
Cell Chem Biol; 2021 Oct; 28(10):1528-1538.e4. PubMed ID: 34081921
[TBL] [Abstract][Full Text] [Related]
18. Controlled Delivery of BET-PROTACs: In Vitro Evaluation of MZ1-Loaded Polymeric Antibody Conjugated Nanoparticles in Breast Cancer.
Cimas FJ; Niza E; Juan A; Noblejas-López MDM; Bravo I; Lara-Sanchez A; Alonso-Moreno C; Ocaña A
Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33086530
[TBL] [Abstract][Full Text] [Related]
19. PROTAC-Design-Evaluator (PRODE): An Advanced Method for In-Silico PROTAC Design.
A S BG; Agrawal D; Kulkarni NM; Vetrivel R; Gurram K
ACS Omega; 2024 Mar; 9(11):12611-12621. PubMed ID: 38524483
[TBL] [Abstract][Full Text] [Related]
20. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase.
Smith BE; Wang SL; Jaime-Figueroa S; Harbin A; Wang J; Hamman BD; Crews CM
Nat Commun; 2019 Jan; 10(1):131. PubMed ID: 30631068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
